Poseida Therapeutics: Funding, Investors & Team (Aug 2026)
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors. Poseida Therapeutics was founded in 2014 and is headquartered in San Diego, California.
Poseida Therapeutics has raised $180M across 2 funding rounds on record, the most recent a Post-IPO Equity of $70.0M announced in Aug 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Poseida Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Poseida Therapeutics Funding Rounds
Poseida Therapeutics raised $110M in an undisclosed round announced in Jun 2020.
2.2 years later, a Post-IPO Equity of $70.0M was announced in Aug 2022.
Poseida Therapeutics Founders and Leadership Team
Contact details for the Poseida Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Poseida Therapeutics Funding Compared to Other Biotechnology Startups
Poseida Therapeutics' latest round of $70.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Poseida Therapeutics in Biotechnology and San Diego
Companies Similar to Poseida Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Poseida Therapeutics Funding FAQs
What does Poseida Therapeutics do?
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors. Poseida Therapeutics was founded in 2014 and is headquartered in San Diego, California.
How much funding has Poseida Therapeutics raised?
Poseida Therapeutics has raised $180M across 2 rounds on record. The most recent is a Post-IPO Equity of $70.0M announced in Aug 2022.
When did Poseida Therapeutics last raise funding?
Poseida Therapeutics' most recent funding round on record is a Post-IPO Equity of $70.0M, announced in Aug 2022.
Who is the CEO of Poseida Therapeutics?
Eric Ostertag is listed as CEO at Poseida Therapeutics.
Where is Poseida Therapeutics headquartered?
Poseida Therapeutics is based in San Diego, California, United States.
How many employees does Poseida Therapeutics have?
Poseida Therapeutics is in the 251-500 employee band.
How does Poseida Therapeutics' funding compare to other Biotechnology startups?
Poseida Therapeutics' latest round of $70.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Poseida Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Poseida Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.